The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Author Title [ Type(Asc)] Year
Journal Article
Escudier, B., Roigas J., Gillessen S., Harmenberg U., Srinivas S., Mulder S. F., et al. (2009).  Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma.. J Clin Oncol. 27(25), 4068-75.
Papaxoinis, G., Kotoula V., Giannoulatou E., Koliou G-A., Karavasilis V., Lakis S., et al. (2018).  Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.. Med Oncol. 35(7), 101.
Razis, E., Selviaridis P., Labropoulos S., Norris J. L., Zhu M-J., Song D. D., et al. (2009).  Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.. Clin Cancer Res. 15(19), 6258-66.
Briasoulis, E., Golfinopoulos V., Karina M., Papakostas P., Pavlidis N., & Fountzilas G. (2010).  Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study.. Anticancer Drugs. 21(8), 785-9.
Argiris, A., Karamouzis M. V., Smith R., Kotsakis A., Gibson M. K., Lai S. Y., et al. (2011).  Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer.. Ann Oncol. 22(11), 2482-8.
Iliopoulou, E. G., Kountourakis P., Karamouzis M. V., Doufexis D., Ardavanis A., Baxevanis C. N., et al. (2010).  A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.. Cancer Immunol Immunother. 59(12), 1781-9.
Karavasilis, V., Kotoula V., Pentheroudakis G., Televantou D., Lambaki S., Chrisafi S., et al. (2013).  A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.. J Neurol. 260(6), 1469-80.
M Cappellini, D., Viprakasit V., Taher A. T., Georgiev P., Kuo K. H. M., Coates T., et al. (2020).  A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.. N Engl J Med. 382(13), 1219-1231.
Gavriatopoulou, M., Kastritis E., Kyrtsonis M-C., Vassilakopoulos T. P., Roussou M., Fotiou D., et al. (2017).  Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.. Leuk Lymphoma. 58(6), 1506-1508.
Athyros, V. G., & Mikhailidis D. P. (2012).  Pharmacotherapy: statins and new-onset diabetes mellitus--a matter for debate.. Nat Rev Endocrinol. 8(3), 133-4.
Upadhyay, J., Polyzos S. A., Perakakis N., Thakkar B., Paschou S. A., Katsiki N., et al. (2018).  Pharmacotherapy of type 2 diabetes: An update.. Metabolism. 78, 13-42.
Pilitsi, E., Farr O. M., Polyzos S. A., Perakakis N., Nolen-Doerr E., Papathanasiou A-E., et al. (2019).  Pharmacotherapy of obesity: Available medications and drugs under investigation.. Metabolism. 92, 170-192.
Loutradis, C., & Sarafidis P. (2020).  Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease.. Expert Opin Pharmacother. 21(10), 1201-1217.
Pompili, M., Innamorati M., Gonda X., Serafini G., Erbuto D., Ricci F., et al. (2014).  Pharmacotherapy in bipolar disorders during hospitalization and at discharge predicts clinical and psychosocial functioning at follow-up.. Hum Psychopharmacol. 29(6), 578-88.
Hatzimouratidis, K., Salonia A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., et al. (2016).  Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).. J Sex Med. 13(4), 465-88.
Eardley, I., Donatucci C., Corbin J., El-Meliegy A., Hatzimouratidis K., McVary K., et al. (2010).  Pharmacotherapy for erectile dysfunction.. J Sex Med. 7(1 Pt 2), 524-40.
Kalinderi, K., Fidani L., Katsarou Z., & Bostantjopoulou S. (2011).  Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.. Int J Clin Pract. 65(12), 1289-94.
Ohmasa, F., Saito M., Oiwa H., Tsounapi P., Shomori K., Kitatani K., et al. (2012).  Pharmacological preconditioning of ATP-sensitive potassium channel openers on acute urinary retention-induced bladder dysfunction in the rat.. BJU Int. 110(6 Pt B), E245-52.
Grigoriadis, N. G., Grigoriadis I. G., Markoula S., Paschopoulos M., Zikopoulos K., Apostolakopoulos P. Gr, et al. (2016).  Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim.. Am J Stem Cells. 5(1), 29-38.
Sarafidis, P. A., Georgianos P. I., Malindretos P., & Liakopoulos V. (2012).  Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents.. Expert Opin Investig Drugs. 21(8), 1089-106.
Papademetriou, V., & Papadopoulos C. (2020).  Pharmacological management of diabetic nephropathy.
Patoulias, D., Stavropoulos K., Imprialos K., Athyros V., Doumas M., & Karagiannis A. (2019).  Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice. Curr Vasc Pharmacol.
Giannopoulos, A. A., Giannoglou G. D., & Chatzizisis Y. S. (2016).  Pharmacological approaches of refractory angina.. Pharmacol Ther. 163, 118-31.
Griebeler, M. L., Morey-Vargas O. L., Brito J. P., Tsapas A., Wang Z., Leon B. G. Carranza, et al. (2014).  Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis.. Ann Intern Med. 161(9), 639-49.
Amaniti, A., Sardeli C., Fyntanidou V., Papakonstantinou P., Dalakakis I., Mylonas A., et al. (2019).  Pharmacologic and Non-Pharmacologic Interventions for HIV-Neuropathy Pain. A Systematic Review and a Meta-Analysis.. Medicina (Kaunas). 55(12), 

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.